EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Identification of Potential Diagnostic Biomarkers and Drug Targets for Endometriosis from a Genetic Perspective: A Mendelian Randomization Study

Wenhui Wang, Yingjia Zhu, Feng Cheng, Linling Zhu, Xinyun Yang, Mingjie He, Wenhui Wang

Gynecologic and Obstetric Investigation · 2025

DOI: 10.1159/000543707 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gynecologic and Obstetric Investigation, 2025. Verfasst von Wenhui Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, Hangzhou Women's Hospital, Hangzhou, China. Hauptthemen laut MEDLINE: Endometriosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Endometriosis (EM) is a chronic disease severely impacting reproductive health, with its exact cause still unclear. In-depth understanding of the etiology and pathogenesis of EM from the perspective of genetics and exploring individualized treatment strategies can improve the health and quality of life of patients.

Design

This study combined genetic data analysis with experimental validation to provide novel biomarkers and drug targets for the diagnosis and treatment of EM. Participants/Materials, Setting, and Methods: Whole blood cis-expression quantitative trait loci (eQTL) data were used as exposure data, and data from the FinnGen database EM1-2 and EM3-4 were used as outcomes. Summary-data-based Mendelian randomization (SMR) methods were used to select genes with causal relationship to the disease. These genes were validated through bioinformatics analysis and real-time quantitative polymerase chain reaction (RT-qPCR) analysis of clinical samples, and potential diagnostic and drug targets were screened through colocalization and molecular docking.

Results

Through SMR analysis, seven genes were selected as potential diagnostic markers of EM, namely Eukaryotic Elongation Factor, Selenocysteine-TRNA-Specific (EEFSEC), INO80 complex subunit E (INO80E), RAP1 GTPase-activating protein (RAP1GAP), Lipid Droplet-Associated Hydrolase (LDAH), Ring Finger And SPRY Domain Containing 1 (RSPRY1), HLA Complex Group 22 (Non-Protein Coding) (HCG22), and Adenosine Kinase (ADK). Colocalization analysis showed that EEFSEC, HCG22, INO80E, and RSPRY1 could be used as potential drug targets.

Limitations

SMR is limited by dependence on publicly available summary data, potential confounding biases in genetic variant-phenotype associations, the presence of underlying horizontal pleiotropy, and issues related to insufficient statistical power. Colocalization analysis cannot assess undiscovered genetic variants. The in vitro experiments in this study utilized clinical samples but were validated only at the expression level. The accuracy of molecular docking analysis largely depends on the quality of protein structures and ligands.

Conclusions

The study identifies potential diagnostic markers and drug targets for EM from a genetic perspective, providing new directions for drug development and precision medicine for EM treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndometriosisHumansFemaleMendelian Randomization AnalysisBiomarkersQuantitative Trait LociMolecular Docking Simulation

Stichwörter der Autor:innen

Diagnostic markersDrug targetsEndometriosisGeneticsSummary-data-based mendelian randomization

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Gynecology, Hangzhou Women's Hospital, Hangzhou, China.
  • Department of Orthopedics, The Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
  • Department of Reproductive Endocrinology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Department of General Practice, Yiqiao Community Health Service Center, Hangzhou, China.
  • Department of Pathology, Hangzhou Women's Hospital, Hangzhou, China.

Zitieren

APA

Wang, W., Zhu, Y., Cheng, F., Zhu, L., Yang, X., He, M., & Wang, W. (2025). Identification of Potential Diagnostic Biomarkers and Drug Targets for Endometriosis from a Genetic Perspective: A Mendelian Randomization Study. Gynecologic and Obstetric Investigation. https://doi.org/10.1159/000543707

Vancouver

Wang W, Zhu Y, Cheng F, Zhu L, Yang X, He M, et al. Identification of Potential Diagnostic Biomarkers and Drug Targets for Endometriosis from a Genetic Perspective: A Mendelian Randomization Study. Gynecologic and Obstetric Investigation. 2025. doi:10.1159/000543707

BibTeX
@article{Wang2025,
  author = {Wang, Wenhui and Zhu, Yingjia and Cheng, Feng and Zhu, Linling and Yang, Xinyun and He, Mingjie and Wang, Wenhui},
  title = {Identification of Potential Diagnostic Biomarkers and Drug Targets for Endometriosis from a Genetic Perspective: A Mendelian Randomization Study},
  journal = {Gynecologic and Obstetric Investigation},
  year = {2025},
  doi = {10.1159/000543707}
}
Kostenlos starten →